Three symposia. A third year of Fellows. AI live on the booth floor. Medscape Oncology arrives at ASCO 2026 (Booth #10099) ...

Eli Lilly and UNICEF USA have announced a collaboration aiming to improve non-communicable disease (NCD) prevention and care ...

Amgen and UCB’s novel osteoporosis treatment Evenity has been approved by the FDA, nearly two years after it was first submitted. Evenity (romosozumab) is a first-in-class antibody treatment that ...

AbbVie has appointed Kelly Sanderson Schrems as Vice President and General Manager, UK. Sanderson Schrems succeeds Steve ...

Boehringer Ingelheim and Immunitas Therapeutics have announced a global licensing agreement for a preclinical antibody programme being developed for chronic inflammatory and autoimmune diseases.

Novartis has started construction on its new 46,000 sq. ft radioligand therapy (RLT) manufacturing site in Denton, Texas, the ...

Mental health providers revealed years ago what healthcare is only now beginning to recognise: information alone does not ...

OVID Health has appointed Davide Scalenghe as Head of Global Strategy & Partnerships. In his new role, Scalenghe will focus on expanding the agency’s international footprint across public affairs, ...

The energy is building as we prepare to head to New Orleans, LA, for the annual scientific sessions of the American Diabetes ...

Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of ...

LEO Pharma has announces that it will acquire Replay, a gene therapy company focused on developing transformative treatments for rare genetic dermatological conditions. LEO will pay Replay $50m ...